Pfenex (PFNX) Tops Q3 EPS by 19c
Tweet
Share
E-mailGet Alerts PFNX Hot Sheet
Join SI Premium – FREE
Pfenex (NYSE: PFNX) reported Q3 EPS of ($0.37), $0.19 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $5.02 million versus the consensus estimate of $3.3 million.
For earnings history and earnings-related data on Pfenex (PFNX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Tenon Medical (TNON) Misses Q2 EPS by 395c
- Calamp Corp. (CAMP) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
